The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes

Infection and Immunity

Volumn 79, Issue 4, 2011, Pages 1559-1565

  Belstrøm, Daniel ^a   Holmstrup, Palle ^b   Damgaard, Christian ^a,b   Borch, Tanja S ^a,b   Skjødt, Mikkel Ole ^c   Bendtzen, Klaus ^a   Nielsen, Claus H ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROGENESIS; BACTERIUM ADHERENCE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; NONHUMAN; PERIODONTITIS; PHAGOCYTE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; BACTERIAL ADHESION; CELL ADHESION; CELL SEPARATION; COMPLEMENT ACTIVATION; COMPLEMENT C3; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHAGOCYTES; PORPHYROMONAS GINGIVALIS; YOUNG ADULT;

EID: 79953299900     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01036-10     Document Type: Article

References (46)

1. Amar, S., S. C. Wu, and M. Madan. 2009. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J. Immunol. 182:1584-1592.
2. Aoki, Y., K. Tabeta, Y. Murakami, F. Yoshimura, and K. Yamazaki. 2010. Analysis of immunostimulatory activity of Porphyromonas gingivalis fimbriae conferred by Toll-like receptor 2. Biochem. Biophys. Res. Commun. 398: 86-91.
3. Arbes, S. J., Jr., G. D. Slade, and J. D. Beck. 1999. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J. Dent. Res. 78:1777-1782.
4. Bohnstedt, S., et al. 2010. High antibody levels to P. gingivalis in cardiovascular disease. J. Dent. Res. 89:938-942.
5. Chavarry, N. G., M. V. Vettore, C. Sansone, and A. Sheiham. 2009. The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev. Dent. 7:107-127.
6. Chevalier, J., and M. D. Kazatchkine. 1989. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142:2031-2036.
7. Cutler, C. W., R. R. Arnold, and H. A. Schenkein. 1993. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J. Immunol. 151:7016-7029.
8. Davey, M., et al. 2008. Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J. Immunol. 180:2187-2195.
9. Davies, K. A., A. M. Peters, H. L. Beynon, and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J. Clin. Invest. 90:2075-2083. doi:10.1172/ JCI116090.
10. de Pablo, P., I. L. Chapple, C. D. Buckley, and T. D ietrich. 2009. Periodontitis in systemic rheumatic diseases. Nat. Rev. Rheumatol. 5:218-224.
11. Deshpande, R. G., M. B. Khan, and C. A. Genco. 1998. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun. 66:5337-5343.
12. Dzau, V. J., R. C. Braun-Dullaeus, and D. G. Sedding. 2002. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8:1249-1256. doi:10.1038/nm1102-1249.
13. Fitzpatrick, R. E., L. C. Wijeyewickrema, and R. N. Pike. 2009. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol, 4: 471-487 doi:10.2217/fmb.09.18
14. Friedewald, V. E., et al. 2009. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. Am. J. Cardiol. 104:59-68.
15. Gibson, F. C., III, H. Yumoto, Y. Takahashi, H. H. Chou, and C. A. Genco. 2006. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85:106-121.
16. Ho, Y. S., et al. 2009. Porphyromonas gingivalis fimbriae-dependent interleukin-6 autocrine regulation by increase of gp130 in endothelial cells. J. Periodontal Res. 44:550-556.
17. Holmstrup, P., A. H. Poulsen, L. Andersen, T. Skuldbol, and N. E. Fiehn. 2003. Oral infections and systemic diseases. Dent. Clin. North Am. 47:575-598.
18. Jepsen, H. H., et al. 1990. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients. APMIS 98:637-644.
19. Kalli, K. R., J. M. Ahearn, and D. T. Fearon. 1991. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J. Immunol. 147:590-594.
20. Kato, T., et al. 2007. Virulence of Porphyromonas gingivalis is altered by substitution of fimbria gene with different genotype. Cell. Microbiol. 9:753-765.
21. Kebschull, M., R. T. Demmer, and P. N. Papapanou. 2010. " Gum bug, leave my heart alone!" -epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89:879-902.
22. Lockhart, P. B., et al. 2008. Bacteremia associated with toothbrushing and dental extraction. Circulation 117:3118-3125.
23. Mastragelopulos, N., V. I. Haraszthy, J. J. Zambon, and G. G. Zafiropoulos. 2002. Detection of periodontal pathogenic microorganisms in atheromatous plaque. Preliminary results. Chirurg 73:585-591.
24. Mealey, B. L., and L. F. Rose. 2008. Diabetes mellitus and inflammatory periodontal diseases. Compend. Contin. Educ. Dent. 29:402-403.
25. Medof, M. E., K. Iida, and V. Nussenzweig. 1983. Role of the complement receptor CR1 in the processing of substrate-bound C3. Ann. N. Y. Acad. Sci. 421:299-306.
26. Medof, M. E., and G. M. Prince. 1983. Immune complex alterations occur on the human red blood cell membrane. Immunology 50:11-18.
27. Mercado, F. B., R. I. Marshall, A. C. Klestov, and P. M. Bartold. 2001.Relationship between rheumatoid arthritis and periodontitis. J. Periodontol. 72:779-787. doi:10.1902/jop.2001.72.6.779.
28. Mustapha, I. Z., S. Debrey, M. Oladubu, and R. Ugarte. 2007. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J. Periodontol. 78:2289-2302. doi:10.1902/jop.2007.070140.
29. Nelson, R. A., Jr. 1953. The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 118:733-737.
30. Ng, Y. C., J. A. Schifferli, and M. J. Walport. 1988. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. Clin. Exp. Immunol. 71:481-485.
31. Nielsen, C. H., et al. 2007. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin. Exp. Immunol. 147:287-295.
32. Nielsen, C. H., S. H. Matthiesen, I. Lyng, and R. G. Leslie. 1997. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes. Immunology 90:129-137.
33. Nielsen, C. H., J. M. Rasmussen, A. Voss, P. Junker, and R. G. Leslie. 1998. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Arthritis Rheum. 41:613-622.
34. Nygren, H., G. Dahlen, and L. A. Nilsson. 1979. Human complement activation by lipopolysaccharides from Bacteroides oralis, Fusobacterium nucleatum, and Veillonella parvula. Infect. Immun. 26:391-396.
35. Paccaud, J. P., J. L. Carpentier, and J. A. Schifferli. 1988. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane. J. Immunol. 141:3889-3894.
36. Paju, S., and F. A. Scannapieco. 2007. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 13:508-512.
37. Palarasah, Y., et al. 2010. Sodium polyanethole sulfonate as an inhibitor of activation of complement function in blood culture systems. J. Clin. Microbiol. 48:908-914.
38. Pfeiffer, N. E., D. E. Wylie, and S. M. Schuster. 1987. Immunoaffinity chromatography utilizing monoclonal antibodies. Factors which influence antigen-binding capacity. J. Immunol. Methods 97:1-9.
39. Ross, R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138:S419-S420.
40. Schifferli, J. A., Y. C. Ng, J. Estreicher, and M. J. Walport. 1988. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J. Immunol. 140:899-904.
41. Skuldbol, T., K. H. Johansen, G. Dahlen, K. Stoltze, and P. Holmstrup. 2006. Is pre-term labour associated with periodontitis in a Danish maternity ward? J. Clin. Periodontol. 33:177-183.
42. Socransky, S. S., A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134-144.
43. Stelzel, M., et al. 2002. Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J. Periodontol. 73:868-870. doi:10.1902/jop.2002.73.8.868.
44. von der Thusen, J. H., J. Kuiper, T. J. van Berkel, and E. A. Biessen. 2003. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol. Rev. 55:133-166. doi:10.1124/pr.55.1.5.
45. Zahlten, J., et al. 2007. Porphyromonas gingivalis dihydroceramides induce apoptosis in endothelial cells. J. Dent. Res. 86:635-640.
46. Zhang, Y., et al. 2009. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 296:H1675-H1682.